Wednesday, 13 December 2017
We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Wednesday, 13 December 2017, following the American Society of Hematology Annual Meeting (ASH) in Atlanta (9 – 12 December 2017).
We would like to invite all interested parties to dial in as outlined below:
16:00 - 17:00 CET / 15:00 - 16:00 GMT
10:00 - 11:00 AM EST / 07:00 - 08:00 AM PST
Audio webcast and conference call will start with presentations by senior management followed by a Q&A session (live access to the speakers), access is viair.roche.com.
Agenda
Roche Hematology Portfolio: ASH update
Sandra Horning, M.D., Executive V.P., Chief Medical Officer and Head Global Product Development
Hemlibra development program overview: updated data in Hemophilia A patients with inhibitors
Gallia Levy, M.D., Ph.D, Global Development Team Leader, Hemlibra
Cristin Hubbard, Lifecycle Leader, Hemlibra
In order to receive your personal dial-in details and expedite your access to the conference call, please pre-register under this link.
If you have not pre-registered, please find the dial-in numbers below, we recommend you to dial in to the conference 10-15 min prior to the scheduled start.
+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 (1) 631 570 5613 (USA Toll Free)
Presentation slides will be posted on the Roche IR website click here.
A replay of the webcast will be available via ir.roche.com.
Best regards,
Karl Mahler
Head of Investor Relations
Loren Kalm
Investor Relations Officer | 
